PATENT CLAIM ANALYSIS

Application Number: 15736339
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-05
Patent Classification: ["514", "080000"]

Abstract:
The present invention relates to synergistic pharmaceutical combinations comprising organic arsenoxide compounds and mTOR inhibitors. Further, the present invention relates to the use of these pharmaceutical combinations in therapy, in particular, treatment of proliferative diseases.

Claim (Index 9):
The synergistic pharmaceutical combination of any one of  claims 1  to  8 , wherein the mTOR inhibitor is a rapalog.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13363558', '13586959', '14075597', '12513159', '12505295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7527684773128851
- 35 USC 102 Novelty (BERT): 0.5280059453963741
- Combined Prediction Score: 0.730292224121234
- Mean Citation Score: 280.894642
- Max Citation Score: 294.6819799999999
- Similarity Product: 172.97404019620174

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test